RSSDementia

Outcomes Assessment in Clinical Trials of Alzheimer’s Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs

Outcomes Assessment in Clinical Trials of Alzheimer’s Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs

| February 1, 2017 | 0 Comments

by Holly Posner, MD, MS; Rosie Curiel, PsyD; Chris Edgar, PhD; Suzanne Hendrix, PhD; Enchi Liu, PhD; David A. Loewenstein, PhD; Glenn Morrison, MSc, PhD; Leslie Shinobu, PhD; Keith Wesnes, BSc, PhD, FSS, CPsychol, FBPsS; and Philip D. Harvey, PhD Dr. Posner is with Pfizer Inc., New York, New York; Drs. Curiel, Loewenstein, and Harvey […]

Continue Reading

Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer’s Disease Spectrum

Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer’s Disease Spectrum

| February 1, 2017 | 0 Comments

by Philip D. Harvey, PhD; Stephanie Cosentino, PhD; Rosie Curiel, PhD; Terry E. Goldberg, PhD; Jeffrey Kaye, MD; David Loewenstein, PhD; Daniel Marson, PhD, JD; David Salmon, PhD; Keith Wesnes, PhD; and Holly Posner, MD Drs. Harvey, Curiel, and Loewenstein are with the University of Miami Leonard Miller School of Medicine, Department of Psychiatry and Behavioral Sciences, Miami, Florida; […]

Continue Reading

Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study

Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study

| October 9, 2016 | 0 Comments

by Franco Di Cesare, MD; Jessica Mancuso, PhD; Brian Silver, MD; and Peter T. Loudon, PhD Dr. Di Cesare is with Leoben Research Limited in Glasgow, UK; Dr. Mancuso is with Research Statistics at Pfizer in Groton, Connecticut, USA; Dr. Silver is with Rhode Island Hospital and Alpert Medical School of Brown University in Providence, Rhode […]

Continue Reading

Fahr’s Disease or Fahr’s Syndrome?

Fahr’s Disease or Fahr’s Syndrome?

| August 1, 2016 | 0 Comments

by Malathi Latha Perugula, MD, and Steven Lippmann, MD The authors are from the Department of Psychiatry and Behavioral Science, University of Louisville School of Medicine, Louisville, Kentucky. Innov Clin Neurosci. 2016;13(7–8):45–46

Continue Reading

Letter to the editor: Diagnosing Disorder of Consciousness: The Opening of Pandora’s Box!

Letter to the editor: Diagnosing Disorder of Consciousness: The Opening of Pandora’s Box!

| April 1, 2016 | 0 Comments

Dear Editor: Consciousness is a multifaceted concept that has two major components: awareness of environment of self (i.e., the content of consciousness) and wakefulness (i.e., the level of consciousness). Whereas the level of arousal reflects the overall state of activity in the brain, conscious awareness is a more dynamic and complex process involving various cerebral […]

Continue Reading

Quetiapine-induced Bradycardia and Hypotension in the Elderly—A Case Report

Quetiapine-induced Bradycardia and Hypotension in the Elderly—A Case Report

| February 1, 2016 | 0 Comments

by Masaru Nakamura, MD, PhD; Megumi Seki, MD; Yosuke Sato, MD; and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Dr. Seki is with the Department of Internal Medicine, and Dr. Satoh is with the Department of Psychiatry, Kosekai-Kusatsu Hospital, Hiroshima; and Dr. Nagamine is with the Department of […]

Continue Reading